We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

With Divestitures, Schering Gets OK To Buy Rival

Law360 (November 16, 2007, 12:00 AM EST) -- Schering-Plough Corp. received a thumbs up on its $14.4 billion takeover of an Akzo-Nobel NV unit on Friday, after it agreed to sell off certain assets in response to regulatory concerns that the deal could harm competition in the poultry vaccine market.

A day after the Federal Trade Commission lodged a complaint challenging Schering-Plough's bid to buy Akzo-Nobel's Organon BioSciences NV, the regulator announced that the pharmaceutical giant had agreed to divest the rights and assets it needs to develop and sell three types of poultry...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.